Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monthly subcutaneous Mircera for anemia in non-dialysis chronic kidney disease
2007-005528-34Phase 4Completed
- Sponsor
- Roche
- Start
- Jan 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Epoetin alfa RB in Uraemic Anaemia, sponsored by Roche. Primary endpoint: Hemoglobin correction and/or maintenance during first 8 weeks. Started Jan 2008; status: completed.
02
Drugs
Epoetin alfa RB
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on 2007-005528-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005528-34.